theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Psychiatry

Addiction Medicine   

Questions discussed in this category


What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?
Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.
2 Answers available

Do you routinely prescribe naloxone at discharge for patients with a known history of opioid use disorder?
2 Answers available

How do you approach weaning patients off of buprenorphine?
8 Answers available
237852315423267


Papers discussed in this category


Journal of addiction medicine, 2021 May-Jun 01
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.

The American journal on addictions, 2023 Mar 20
Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine.

Related Topics in Psychiatry

  • Breast Cancer
  • Head and Neck Cancers
  • Radiation Oncology
  • Neuro-Oncology
  • Pediatric Hematology/Oncology
  • Ethics
  • Medical Oncology
  • Biologic Therapy/Immunobiology
  • Epilepsy
  • General Internal Medicine

Copyright © 2025 theMednet
All Rights Reserved.